Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Evolus Inc

EOLS
Current price
12.11 USD +0.14 USD (+1.17%)
Last closed 11.88 USD
ISIN US30052C1071
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 866 238 144 USD
Yield for 12 month +34.26 %
1Y
3Y
5Y
10Y
15Y
EOLS
21.11.2021 - 28.11.2021

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Address: 520 Newport Center Drive, Newport Beach, CA, United States, 92660

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23.43 USD

P/E ratio

Dividend Yield

Current Year

+202 085 000 USD

Last Year

+148 616 000 USD

Current Quarter

+60 164 000 USD

Last Quarter

+66 909 000 USD

Current Year

+135 393 001 USD

Last Year

+92 729 000 USD

Current Quarter

+41 941 000 USD

Last Quarter

+46 405 000 USD

Key Figures EOLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -26 272 000 USD
Operating Margin TTM -21.36 %
PE Ratio
Return On Assets TTM -9.93 %
PEG Ratio
Return On Equity TTM -861.68 %
Wall Street Target Price 23.43 USD
Revenue TTM 248 326 000 USD
Book Value 0.093 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 22.1 %
Dividend Yield
Gross Profit TTM 92 729 000 USD
Earnings per share -0.91 USD
Diluted Eps TTM -0.91 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -22.33 %

Dividend Analytics EOLS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EOLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EOLS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 90.9091
Enterprise Value Revenue 3.6689
Price Sales TTM 3.4883
Enterprise Value EBITDA -21.4983
Price Book MRQ 147.0693

Financials EOLS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EOLS

For 52 weeks

8.31 USD 17.82 USD
50 Day MA 16.22 USD
Shares Short Prior Month 4 840 889
200 Day MA 13.75 USD
Short Ratio 7.97
Shares Short 4 985 273
Short Percent 8.07 %